Eye Movements Recording Using a Mobile : Comparison to Standard Video-oculography in Young Athletes

NCT05211752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2022-05-18

No results posted yet for this study

Summary

This study aims to compare measurements obtained through the e-VOG application (mobile application, usable on smartphones or tablets, to measure eye movements) with measurements from the standard video-oculography device (Eye-Tracker®T2), in young athletes.

Conditions

  • Healthy

Interventions

OTHER

eVOG (Mobile VideoOculoGraphy)

* Eyes movements assessed with e-VOG (mobile application, that uses the face detection features of the front camera to detect and record eye movements). * Study duration is about 20 minutes, the day the subject performs his standard video-oculography examination in routine care (using Eye-Tracker®T2)

Sponsors & Collaborators

  • Centre Hospitalier Princesse Grace

    collaborator OTHER
  • Centre Hospitalier Universitaire de Nice

    collaborator OTHER
  • Association Sportive Monaco Football Club

    collaborator UNKNOWN
  • Association de Recherche Bibliographique pour les Neurosciences

    lead OTHER

Principal Investigators

  • Mikael COHEN, MD · Centre de Ressources et de Compétences SEP, UMRC Pasteur 2, Université Nice Côte d'Azur, Nice-France

  • Sandrine LOUCHART de la CHAPELLE, MD-PHD · Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital, Monaco

  • Alain PESCE, PUPH · Association de Recherche Bibliographique pour les Neurosciences

  • Sylvain BLANCHARD, MD-PHD · Association Sportive Monaco Football Club

Eligibility

Min Age
15 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2022-02-22
Completion
2022-02-22

Countries

  • Monaco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05211752 on ClinicalTrials.gov